agilon health, inc. (NYSE:AGL - Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $3.05 and last traded at $3.05, with a volume of 436205 shares trading hands. The stock had previously closed at $3.67.
Analyst Upgrades and Downgrades
AGL has been the topic of several research reports. Bank of America lowered agilon health from a "buy" rating to an "underperform" rating and set a $3.00 target price on the stock. in a research report on Wednesday. Deutsche Bank Aktiengesellschaft reduced their price objective on agilon health from $5.00 to $4.00 and set a "hold" rating on the stock in a research note on Friday, August 9th. Benchmark reissued a "buy" rating and set a $9.00 target price on shares of agilon health in a research report on Thursday, August 8th. Royal Bank of Canada reiterated an "outperform" rating and set a $8.00 price objective on shares of agilon health in a research note on Wednesday, August 7th. Finally, Evercore ISI increased their price objective on shares of agilon health from $5.50 to $7.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 9th. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $8.22.
View Our Latest Stock Report on AGL
agilon health Trading Down 2.7 %
The firm has a market cap of $1.47 billion, a price-to-earnings ratio of -5.01 and a beta of 0.54. The business's 50 day moving average price is $4.71 and its 200-day moving average price is $5.43. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36.
agilon health (NYSE:AGL - Get Free Report) last issued its earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The company had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The business's revenue was up 38.7% on a year-over-year basis. During the same quarter last year, the firm earned ($0.04) EPS. Equities analysts expect that agilon health, inc. will post -0.32 EPS for the current year.
Insiders Place Their Bets
In related news, CEO Steven Sell bought 20,000 shares of the firm's stock in a transaction on Thursday, September 12th. The stock was bought at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 3.20% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On agilon health
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Neo Ivy Capital Management acquired a new stake in shares of agilon health in the 4th quarter worth approximately $47,000. J.Safra Asset Management Corp boosted its stake in agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock valued at $27,000 after purchasing an additional 3,625 shares in the last quarter. CWM LLC increased its position in shares of agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company's stock valued at $59,000 after purchasing an additional 7,288 shares during the period. Nisa Investment Advisors LLC bought a new stake in shares of agilon health in the 2nd quarter worth $60,000. Finally, Bleakley Financial Group LLC acquired a new stake in shares of agilon health in the first quarter valued at $65,000.
About agilon health
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Stories
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
